Integrase-independent HIV-1 infection is augmented under conditions of DNA damage and produces a viral reservoir. by Ebina, Hirotaka et al.
Title Integrase-independent HIV-1 infection is augmented underconditions of DNA damage and produces a viral reservoir.
Author(s)Ebina, Hirotaka; Kanemura, Yuka; Suzuki, Yasutsugu; Urata,Kozue; Misawa, Naoko; Koyanagi, Yoshio
CitationVirology (2012), 427(1): 44-50
Issue Date2012-05-25
URL http://hdl.handle.net/2433/154921





Title  1 
Integrase-independent HIV-1 infection is augmented under conditions of 2 
DNA damage and produces a viral reservoir  3 
 4 
Hirotaka Ebina*, Yuka Kanemura, Yasutsugu Suzuki, Kozue Urata, Naoko 5 
Misawa and Yoshio Koyanagi 6 
 7 
Laboratory of Viral Pathogenesis, Institute for Virus Research, Kyoto 8 
University, 53 Shogoin-kawara-cho, Sakyo-ku, Kyoto 606-8507, Japan 9 
 10 
* Corresponding author 11 
Laboratory of Viral Pathogenesis, Institute for Virus Research, Kyoto 12 
University, 53 Shogoin-kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan 13 
Phone: +81-75-751-4813 14 




HIV-1 possesses a viral protein, integrase (IN), which is necessary 18 
for its efficient integration in target cells.  However, it has been reported 19 
that an IN-defective HIV strain is still capable of integration.  Here, we 20 
assessed the ability of wild type (WT) HIV-1 to establish infection in the 21 
presence of IN inhibitors. We observed a low, yet clear infection of 22 
inhibitor-incubated cells infected with WT HIV which was identical to cells 23 
infected with IN-deficient HIV, D64A. Furthermore, the IN-independent 24 
integration could be enhanced by the pretreatment of cells with 25 
DNA-damaging agents suggesting that integration is mediated by a DNA 26 
repair system. Moreover, significantly faster viral replication kinetics with 27 
augmented viral DNA integration was observed after infection in irradiated 28 
cells treated with IN inhibitor compared to nonirradiated cells. Altogether, 29 
our results suggest that HIV DNA has integration potential in the presence 30 









Retroelements, such as long terminal repeat 38 
(LTR)-retrotoransposons, non-LTR-retrotransposons, and retroviruses, 39 
insert their reverse transcribed cDNA into the host chromosome during viral 40 
replication. To carry out efficient replication, the retrovirus family has robust 41 
integration machinery consisting of the retrovirus integrase (IN), which 42 
executes the insertion of viral cDNA into the genome of host cells. The IN 43 
protein consists of three distinct domains (Craigie, 2001): the N-terminal 44 
domain contains an HHCC motif; the catalytic core domain in the center of 45 
INs possesses a DDE motif that mediates catalysis; and the C-terminal 46 
domain of IN has little sequence conservation yet possesses nonspecific DNA 47 
binding activity.  48 
It has been reported that human immunodeficiency virus type 1 49 
(HIV-1) cDNA is preferentially inserted into the gene coding region of the 50 
host genome (Schroder et al., 2002). The host lens epithelium-derived growth 51 
 5 
factor/p75 (LEDGF/p75) protein directly binds IN (Llano et al., 2004; 52 
Maertens et al., 2003) and recruits a pre-integration complex consisting of 53 
viral cDNA, host proteins and viral proteins to the gene coding region 54 
(Cherepanov et al., 2005; Engelman and Cherepanov, 2008; Shun et al., 55 
2007). The genome position of inserted HIV-1 provirus is thought to 56 
determine the magnitude of viral gene expression. In fact, transcription of 57 
provirus integrated into gene coding regions is extremely high and produces 58 
large amounts of viral particles (Wang et al., 2007). In contrast, the 59 
transcription of proviruses inserted outside of the gene coding region is 60 
relatively dormant and has a potential for persistent and latent infection 61 
(Brady et al., 2009; Skupsky et al., 2010).  62 
INs dramatically increase the efficiency of viral nucleic acid 63 
insertion into the host DNA, however, other mechanisms for exogenous 64 
nucleic acid incorporation may also exist. Accumulating lines of evidence 65 
indicate that foreign nucleic acids, not related retroelements, can be inserted 66 
into the genome of host cells. For instance, transfected plasmid DNA (Suzuki 67 
 6 
et al., 2010), a DNA virus genome (Dall et al., 2008), mitochondorial DNA 68 
fragments (Nitz et al., 2004) and borna virus cDNA (Horie et al., 2010) have 69 
been reported to integrate into host chromatin DNA despite the absence of 70 
an IN enzyme. The host DNA repair system which involves homologous 71 
recombination or non-homologous end joining appears to be involved in the 72 
insertion (Horie and Tomonaga, 2011).  73 
In this study, we first tested the integration of HIV with a mutated 74 
IN lacking catalytic activity. We could detect a low but significant amount of 75 
integrated HIV cDNA. Because integration is essential for HIV-1 replication, 76 
IN inhibitors have been developed and used as an antiviral therapy for HIV 77 
(Summa et al., 2008). We tested the illegitimate integration of WT HIV in 78 
the presence of IN inhibitors. A low frequency of integration was observed in 79 
the presence of an IN inhibitor which capable of producing infectious virus 80 
particles, and the level of integration was clearly enhanced under 81 
DNA-damaged condition. Our results suggest that retroviral cDNA is 82 
inserted into the host chromosome through host DNA repair machinery via 83 
 7 




Generation of provirus and stable expression of HIV-1 in the absence of IN 87 
activity 88 
 89 
We initially used a vesicular stomatitis virus (VSV)-G pseudotyped 90 
EGFP-expressing HIV vector packaged with a catalytically inactive HIV-1 91 
IN, which contains a D64V mutation. Jurkat cells were infected with varying 92 
amounts of the D64V mutant virus corresponding to the amount of p24CA 93 
used at a multiplicity of infection (MOI) of 1, 5 and 10 of wt virus. Cells were 94 
also infected with IN-proficient WT virus at an MOI ranging from 1-10 in the 95 
absence or presence of IN inhibitors, Elvitegravir (Elv) or Raltegravir (Ral). 96 
To ensure the removal of unintegrated HIV-1 DNA associated with cell 97 
division, the cells were further cultured for 2 weeks and the levels of 98 
unintegrated, 2LTR, and integrated HIV-1 DNA were assessed. As shown 99 
Fig.1A, the increased integrated but not unintegrated viral DNA was 100 
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detected with increasing MOI in WT+Elv- and D64V-infected cells. Based on 101 
this result, we calculated the efficiency of integration during an IN-deficient 102 
condition to be 0.1-0.2% of WT integration (Fig.1B). We further assessed 103 
green fluorescent protein (GFP) transduction efficiency by flow cytometry 104 
analysis and observed a dose dependent GFP transduction under 105 
IN-deficient conditions, in WT+Elv or WT+Ral, and D64V-infected cells 106 
(Fig.1C). Up to 2.3% GFP positive cells were detected in D64V mutant 107 
infected cells. The copy number of integrated viral DNA highly correlated 108 
with the transduction efficiency (R=0.9019 > 0.590; α=0.01) (Fig.1D). These 109 
results indicated that the transduction was from the integrated form of 110 
HIV-1 DNA. Therefore, we assumed that the level of GFP expression 2 weeks 111 
after infection using this HIV vector was representative of the level of 112 
integrated DNA.  113 
It has been shown that the introduction of a 114 
DNA double-stranded break in a target gene can stimulate 115 
retrotransposition of LINE-1, gene targeting and genome rearrangement 116 
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(Francis and Richardson, 2007; Morrish et al., 2002; Richardson and Jasin, 117 
2000). To test whether DNA damage augments integration activity of HIV-1 118 
lacking IN activity, cells were exposed to various doses of gamma irradiation 119 
in order to induce DNA double-strand breaks (DSB) before virus infection 120 
and then flow cytometry analysis was performed two weeks post infection 121 
(Fig. 1E).  The percentage of GFP positive cells was clearly augmented and 122 
correlated with increasing doses of gamma irradiation. Furthermore, we also 123 
examined the effect of chemical-induced DNA damage by hydrogen peroxide 124 
in IN-deficient HIV-1 integration. Significant enhancement of GFP 125 
transduction of IN-deficient HIV was observed in cells treated with hydrogen 126 
peroxide in a dose dependent manner (Fig. 1F). Finally, we directly analyzed 127 
the copy number of integrated HIV-1 DNA in the cells used in Fig. 1E and F. 128 
(Fig. 1G and H, respectively). The efficiency of integration under IN-deficient 129 
conditions was augmented from 0.1% to 1.7% depending on the dose of DNA 130 
damage. These results suggested that the induction of DNA damage in target 131 
cells enhanced the efficiency of retroviral IN-independent integration. 132 
 11 
Moreover these findings suggest that HIV uses a host DNA repair system for 133 
the IN-independent integration. 134 
 135 
Attenuation of HIV-1 gene expression from proviruses established through 136 
an IN-independent pathway 137 
 138 
We showed that HIV-1 DNA was inserted into the host chromosome 139 
without IN activity. To examine the LTR promoter activity and level of gene 140 
expression from IN-independent proviruses, VSV-G pseudotyped LTIG 141 
(LTR-Tat-IRES-GFP) vector was used. The HIV tat protein, an accessory 142 
protein responsible for regulating HIV transcription, is expressed under the 143 
regulation of an LTR promoter and the transcriptional level can be 144 
monitored by GFP expression. As expected, a parallel transduction of Jurkat 145 
cells with GFP-expressing WT virus in the presence of Elv and D64V mutant 146 
virus in increasing doses was observed (Fig. 2A and B). However, the mean 147 
fluorescence intensity (MFI) was significantly lower in cells infected with 148 
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LTIG virus in the presence of Elv and D64V mutant compared with that of 149 
WT virus without Elv (Fig. 2A and C). Furthermore, we isolated 17, 10 and 150 
20 cell clones from WT virus infected cells without IN inhibitor, WT virus 151 
infected cells with inhibitor, and D64V virus infected cells, respectively. The 152 
level of GFP expression in each clone was analyzed by flow cytometry as 153 
shown in Fig.2D. The isolated cell clones were divided into two groups, 154 
IN-dependent (WT) and IN-indendent (WT+Elv and D64V) transduction. 155 
Then, the frequency of distribution based on the MFI of GFP expression is 156 
shown in Fig. 2E. Chi-square distribution was assessed and statistically 157 
significant difference between IN-dependent and independent groups was 158 
observed (χ2=10.927>9.488; four-degree-of-freedom, P=0.05). 159 
Given that the chromatin environment near the provirus is known 160 
to affect the level of viral gene expression, we attempted to address this 161 
possibility by analyzing the integration sites of proviruses (Table 1). In 162 
WT-infected cells, 84% of the integration sites were detected in gene coding 163 
regions as shown RefSeq, while only 68% of the events were detected in gene 164 
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coding regions under IN-deficient condition.  Although, we could not find 165 
statistically significant differences (P=0.098) under these parameters, if we 166 
analyzed the frequency of viral DNA insertion in respect to the presence of 167 
repeat sequences, then significant differences were observed (2% vs. 19%; 168 
P=0.0048). Furthermore, the deletion and insertion of nucleotides in the 169 
junction of LTR-genomic DNA was a frequent feature in the IN-deficient 170 
mutant as shown in a previous report (6% vs. 27%; P=0.0039) (Gaur and 171 
Leavitt, 1998). These results suggest that the HIV integration pattern is 172 
modified under IN-deficient conditions and it may cause reduced promoter 173 
activity. 174 
 175 
Formation of an intact HIV-1 reservoir under IN-deficient conditions 176 
 177 
Here, we showed a lower level of viral gene expression from the 178 
provirus generated through an IN-independent pathway. To test the ability 179 
of replication-competent HIV-1 to produce infectious virus under 180 
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IN-suppressed conditions, we performed the experiment depicted in Fig. 3A. 181 
Irradiated or untreated Jurkat cells were infected with replication 182 
competent HIV-1 NL4-3 in the presence of an IN inhibitor. Three days after 183 
infection, the IN inhibitor and free viral particles were removed with 184 
extensive washing, followed by the addition of fresh Jurkat cells (as 185 
indicated day 0). p24CA viral antigen in culture supernatant was monitored. 186 
Under nonirradiated culture conditions, the peak of p24CA was observed at 187 
days 9 and 11 after the removal of IN inhibitor. In contrast, faster viral 188 
replication was observed in the irradiated culture. The peak of viral 189 
replication was observed at 5 days post infection (dpi) (Fig. 3B). The amount 190 
of integrated and 2LTR proviral DNA at day 0 was performed by 191 
quantitative PCR and we found that the irradiated culture contained a 192 
fivefold higher amount of integrated provirus than the nonirradiated culture. 193 
On the other hand, there was no significant difference in the copy number of 194 
2LTR cDNA between irradiated and non-irradiated cultures, suggesting that 195 
DNA damage before viral infection increased the HIV cDNA insertion under 196 
 15 





Previously, Gaur et al. reported that mutant HIV lacking IN activity 201 
due to mutations in a highly conserved DDE motif of IN is able to integrate 202 
into the host chromosome (Gaur and Leavitt, 1998). Here, we showed that 203 
not only an IN-deficient virus, but also WT virus in the presence of an IN 204 
inhibitor is integrated into the host chromosome. The efficiency of HIV 205 
integration when using an IN antagonist was only 0.1-0.2% of IN mediated 206 
integration, indicating that the IN-independent integration pathway may be 207 
only a minor pathway or accidental event in vivo. However, we showed that 208 
stress inducing DNA damage enhances IN-independent infection of cells by 209 
HIV and has the potential to serve as a virus reservoir, thus suggesting that 210 
it may play a role in disease progression. For instance, although combination 211 
antiretroviral therapy (cART) has reduced the pathogenesis of AIDS-related 212 
malignancies, there has been an increase of HIV- positive patients with 213 
non-AIDS-defining malignancies such as Hodgkin’s lymphoma, invasive anal 214 
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carcinoma, lung cancer, skin cancers, and hepatocellular carcinoma (Spano 215 
et al., 2008). Radiotherapy is a standard treatment procedure for many 216 
individuals with cancer and HIV, even though it may adversely affect HIV 217 
disease status and CD4 counts (Housri et al., 2010). Our results suggest that 218 
patients receiving simultaneous medical treatment for cancer in the form of 219 
radiation and anticancer drug therapy may be at a higher risk for DNA 220 
repair mediated integration of proviral cDNA. In addition, it is conceivable 221 
that even mental stress-induced radical oxidents may augment 222 
IN-independent infection (Adachi et al., 1993; Morimoto et al., 2008). 223 
Another interesting point of our study is that the level of gene expression 224 
under IN-deficient conditions is reduced when compared with functional IN 225 
infection. Altogether, the IN-independent integration enhanced by the stress 226 
may lead to latent infection in vivo. 227 
The mechanism of IN-independent integration remains to be 228 
elucidated. Previously, Gaur et al. sequenced the host-virus junction and 229 
showed that IN-independently integrated provirus do not have a duplicate 230 
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5-bp repeat of host cell DNA which is characteristically generated by the 231 
staggered cleavage of host DNA during the strand transfer reaction of HIV 232 
(Gaur and Leavitt, 1998). They also demonstrated that the integrated DNA 233 
of IN defective virus includes the deletion of host DNA, LTR, and the 234 
insertion of unknown sequences between the virus-host DNA junction. Based 235 
on these results, they suggested that the integration of HIV lacking IN 236 
activity may be catalyzed by the host DNA repair system (Gaur and Leavitt, 237 
1998). In line with their findings, our results also demonstrate a significant 238 
increase in the deletion and insertion of nucleotides at virus-host DNA 239 
junctions in cells infected with an IN-deficient virus (WT: 6% vs. 240 
IN-deficient: 27%, P=0.0039). Furthermore, induced DNA damage in target 241 
cells before virus infection increased the level of integration (Fig. 1G and H). 242 
These findings support the idea that HIV DNA is inserted into a DNA break 243 
point by the host DNA repair system, possibly by non-homologous end 244 
joining and/or homologous recombination. 245 
It has been reported that the provirus integration site determines 246 
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the level of viral gene expression (Wang et al., 2007). The host protein 247 
LEDGF/p75 promotes HIV integration into active gene coding regions (Shun 248 
et al., 2007). However, silencing of the active provirus integrated at gene 249 
coding regions is challenging, making it unclear how latently infected cells 250 
are established. In this paper, we demonstrated that the level of gene 251 
expression is reduced depending on distinct integration pathways. To 252 
understand the mechanism of gene silencing, we analyzed integration sites 253 
of HIV-1 proviruses. Unexpectedly, the integration site analysis focused on 254 
gene coding sequences did not show significant differences between the 255 
targeted frequency of integration under IN-deficient and conventional 256 
conditions. However, HIV-1 cDNAs were frequently inserted into 257 
minisatellite-like repeat sequences of genomic DNA in IN-deficient 258 
conditions (P=0.0048). Minisatellites consist of 10-100 bp repeat sequences 259 
and is observed near cis-acting meiotic double-strand break hotspots 260 
(Richard and Paques, 2000). If the IN-independent integration is carried out 261 
by the DNA repair pathway, then double-strand break hotspots may be the 262 
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target for the insertion. Moreover, an unknown determinant for these 263 
hotspots, such as the chromatin environment, may cause reduced gene 264 
expression.  265 
In our study, the integration frequency of provirus into gene coding 266 
regions was 68% under an IN-deficient condition and it was much higher 267 
than predicted random integration (33%). Hence, this result suggests that 268 
there is an integration preference into gene coding regions even during 269 
IN-independent integration. One plausible explanation for this may be 270 
attributed to the sensitivity of the host chromosome to DNA breaks at gene 271 
coding regions. If the retroviral DNA is inserted at a DNA break point under 272 
IN-independent conditions, our results might reflect a high frequency of 273 
DNA breaks that occur at gene coding regions in the host chromosome. 274 
Another possibility is that LEDGF/p75 may promote viral cDNA tethering to 275 
the gene coding region even under IN-deficient conditions the same as it 276 
would if functional IN was present. We used a lentivirus vector that has a 277 
mutation in the catalytic domain of IN. It has been reported that the 278 
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mutation at D64 to alanine in IN does not inhibit the protein binding with 279 
LEDGF/p75 (Cherepanov et al., 2005).  In addition, the binding interface of 280 
IN and LEDGF/p75 does not overlap with the active site of IN inhibitors 281 
(Hare et al., 2010; Michel et al., 2009). Therefore, it is not surprising that 282 
retroviral DNA preferentially integrated into gene coding regions even when 283 
IN is devoid of function.  284 
In sum, our findings serve as a caveat for an alternative infection 285 
route that HIV can take during DNA damage to bypass a drug therapy 286 
involving IN inhibitors. The analysis of integrated provirus obtained from 287 
HIV-positive patients after radiotherapy will shed light on the practical risk 288 
of the alternative infection pathway of HIV in vivo. 289 
290 
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Materials and Methods 291 
 292 
Virus preparation 293 
 294 
Human embryonic kidney (HEK) 293T cells were used for virus 295 
preparation. HEK293T cells were transfected by the calcium phosphate 296 
method as described previously (Kawano et al., 2004). The culture 297 
supernatants at 48 hr post-transfection were centrifuged and filtrated. To 298 
prepare HIV-1 NL4-3, cells were transfected pNL4-3 and the 50% tissue 299 
culture infective dose (TCID50) was calculated (Kawano et al., 1997; Sato et 300 
al., 2008). To prepare the EGFP-expressing HIV vector, pCS-CDF-EG-Pre 301 
was used. pCS-CDF-EG-Pre was constructed by exchanging the CMV 302 
promoter of pCS-CDF-CG-Pre (Miyoshi et al., 1998) with human elongation 303 
factor 1α (EF) promoter. The pCS-CDF-EG-Pre was transfected together 304 
with packaging plasmids pMD.G, pMDLg/pRRE and pRSV Rev (Kawano et 305 
al., 2004). To prepare VSV-G pseudotyped WT LTIG vector, pEV731, kindly 306 
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provided by Dr. Eric Verdin (Jordan et al., 2003), pMD.G, pMDLg/pRRE and 307 
pRSV Rev were cotransfected. To prepare IN-deficient D64V mutant virus, 308 
pMDKg/pRRE/D64V, kindly provided by Dr. Ikawa (Okada et al., 2009), were 309 
used instead of pMDLg/pRRE. The infectious dose of GFP expressing vectors 310 
was assessed as follows. Two hundreds thousand of Jurkat cells were 311 
infected with serial volumes of stock virus in 1 ml culture. At 3 days after 312 
infection, GFP positive cells were analyzed by flow cytometry and the 313 
infectious dose were calculated based on the input volume of virus counted 314 




To quantify the viral antigen p24CA in virus solutions, an HIV-1 p24 319 
antigen enzyme linked immunosorbent assay (ELISA) kit (ZetroMetrix 320 
Buffalo, NY) was used. 321 
 322 
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Cell culture 323 
 324 
HEK293T cells were maintained in Dulbecco’s Modified Eagle 325 
Medium (DMEM) containing 10% fetal calf serum (FCS), 100 U/ml penicillin 326 
and 100 g/ml streptomycin. Jurkat cells were maintained in RPMI 1640 327 
medium containing 10% FCS, 100 U/ml penicillin and 100 g/ml 328 
streptomycin. 329 
 330 
Pseudotyped virus infection and flow cytometry analaysis 331 
 332 
To infect with pseudotyped EGFP-expressing HIV vector or LTIG 333 
virus, Jurkat cells (2 x 105 cells) were infected with a pseudotyped virus 334 
solution as corresponded as the infectious dose of WT virus at indicated MOI. 335 
Under IN-deficient conditions, 1 µM Ral (NIH, Bethesda, MD) or 100 nM Elv 336 
(Selleck Chemicals, Houston, TX) were added in the culture medium. Two 337 
weeks after infection, the percentage of GFP positive cells were measured by 338 
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flow cytometry. Cells were suspended in phosphate-buffered saline (PBS) 339 
containing 1% formamide. Flow cytometry was performed with a 340 
FACSCalibur (BD Biosciences), and data were analyzed using CellQuest 341 
software (BD Biosciences). 342 
 343 
Cell cloning 344 
 345 
GFP+ Jurkat cells were sorted from the bulk culture 2 weeks after 346 
pseudotyped LTIG virus infection by FACSAria (BD Biosciences) and cell 347 
cloning was carried out by limiting dilution method. 348 
 349 
Induction of DNA damage in target cells 350 
 To induce DNA damages with ionizing radiation, Jurkat cells (2 x 351 
105 cells/ml) were exposed to appropriate doses (5-10 Gy) of gamma 352 
irradiation at room temperature. Gamma irradiation was performed using a 353 
Faxitron RX-650 (Faxitron bioptcs, Lincolnshire, IL). To induce DNA damage 354 
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with reactive oxygen species, Jurkat cells (2 x 105 cells/ml) were incubated 355 
with medium containing 10, 50 or 100 µM of hydrogen peroxide at 37˚C for 6 356 
hr. The DNA damage-induced cells were immediately used for virus infection 357 
after washing with medium once. 358 
 359 
Analyses of HIV-1 replication kinetics of IN-independent integrated 360 
proviruses  361 
 362 
The irradiated or non-treated Jurkat cells (4 x 104 cells) were 363 
incubated for 2 hr in HIV-1 NL4-3 solution containing 40 ng of p24CA 364 
(TCID50, 984419/ml) at MOI of 1 with 100 nM Elv or 1 µM Ral. After 365 
extensive washing (twice with PBS, once with 5% tripsin/EDTA at 37 ˚C for 5 366 
min, and twice with 10% FCS RPMI), the cells were resuspended and 367 
cultured in 200 µl of 10% RPMI containing an appropriate concentration of 368 
IN inhibitor. After 3 dpi, the cells were extensively washed as mentioned 369 
above. Then, the cells were co-cultured with fresh Jurkat cells (4 x 104 cells) 370 
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in the absence of IN inhibitor. The culture medium was harvested at the 371 
indicated time points and the level of p24CA antigen was measured by 372 
ELISA.  373 
 374 
Quantitative analysis of retroviral DNA 375 
 376 
The amount of proviral, 2LTR, and full-length forms of HIV-1 DNA 377 
was quantified by real-time PCR and the copy number of HIV-1 DNA was 378 
normalized by β-actin as previously described (Suzuki et al., 2003). 379 
Unintegrated linear DNA was calculated by subtracting the copy number of 380 
provirus and 2LTR DNA from that of full-length viral DNA. 381 
 382 
Integration site analyses 383 
 384 
The integration sites were determined by the linker ligation method 385 
described previously (Ciuffi et al., 2009). Briefly, genomic DNA was extracted 386 
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from the GFP positive population using a DNeasy column (QIAGEN) and 387 
digested with AvrII, NheI and XbaI. The digested genomic DNA was ligated 388 
with a linker adapter and then used to perform nested PCR amplification. 389 
The PCR products were cloned into a pGEM-T (Promega, Madison, WI) 390 
vector and sequenced using an M13 primer. 391 
 392 
Statistical analysis 393 
 394 
The student’s t test was used to determine statistical significance. P 395 
values of <0.05, <0.01 and <0.001 were considered significant. The 396 
chi-square test was also used to determine statistical significance from the 397 
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Figure legend 541 
 542 
Fig.1. The transduction and integration efficiency of HIV under IN-deficient 543 
conditions. Jurkat cells were infected with a MOI of 1-10 with WT 544 
EGFP-expressing HIV vector in the absence or presence of 100 nM Elv or 1 545 
µM Ral and indicated as WT, WT+Elv and WT+Ral, respectively. 546 
Alternatively, the IN-deficient mutant virus (D64V) was also used. (A) Two 547 
weeks after infection, the copy number of integrated, 2LTR and unintegrated 548 
forms of viral DNA were analyzed by qPCR. The cell number was determined 549 
quantity by qPCR detecting β-actin. (B) The efficiency of integration under 550 
IN-deficient conditions is shown. The values were calculated by dividing the 551 
integrated copy number of provirus derived from IN-deficient conditions by 552 
that of WT. (C) GFP positive cells were detected by flow cytometry 2 weeks 553 
after infection. Pseudo plots of the raw data analyzed by flow cytometry are 554 
shown. The numbers indicated on the plot show the percentage of GFP 555 
positive cells. These results are summarized in the bar graphs depicted below. 556 
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(D) Coefficient of correlation. The correlation of GFP positive cells (%) and 557 
HIV DNA (copies/1000 cells) are shown. Gray squares indicate WT+Elv (n=9) 558 
and triangles indicate D64V (n=9). Pearson’s product-moment correlation 559 
coefficient was calculated from populations of WT+Elv and D64V (n=18). 560 
(E-H) DNA damage enhanced IN-independent integration. Jurkat cells were 561 
exposed to various doses of gamma radiation, IR (E and G) or hydrogen 562 
peroxide, H2O2 (F and H). The cells induced with DNA breaks were infected 563 
with GFP expressing HIV vector. (E and F) GFP positive cells were analyzed 564 
as mentioned in Fig.1C. Pseudo plots and the summarized graph are shown. 565 
(G and H) The efficiency of integration under  IN-deficient conditions was 566 
calculated as in 1B. The amount of integrated DNA detected in DNA 567 
damage-induced cultures was divided by that obtained in the culture 568 
infected with WT virus without inhibitor and under non-damaged conditions. 569 
All experiments were performed in triplicate (n=3) in A, B, C, E, F and H. 570 
The results of flow cytometry in C, E, and F are data from one experiment, 571 
which is representative of independent experiment. The error bars in A, B, C, 572 
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E, F, G and H show standard deviations.  573 
 574 
Fig. 2. HIV expression from the LTR promoter of IN-independently 575 
generated provirus. Pre-irradiated Jurkat cells were infected with VSV-G 576 
pseudotyped LTIG vector. (A-C) Transduction efficiency of LTIG vector under 577 
IN-deficient conditions with either WT virus in the presence of Elv (WT+Elv) 578 
or D64V mutant virus (D64V). The percentage of GFP positive cells was 579 
analyzed by flow cytometry at 2 weeks after infection. (A) Pseudo plots of the 580 
raw data analyzed by flow cytometry are shown. The bottom numbers 581 
indicated on the plot show the percentage of GFP positive cells, while 582 
underlined numbers indicate the mean fluorescence intensity. The results 583 
are data from one experiment, which is representative of three independent 584 
experiments.  (B) The percentage of GFP positive cells is summarized as the 585 
graph. (C) Magnitude of virus expression from LTR promoter. The MFI of the 586 
GFP expressing cells generated after non-irradiated (0 Gy) or irradiated (5 587 
Gy or 10 Gy) stress is shown. All experiments were performed in triplicate 588 
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(n=3) in B and C. The error bars in A and B show standard deviations. (D) 589 
Clonal cell analysis of viral expression. The GFP positive cells were isolated 590 
from cells shown C and generated clonal cell lines. The MFI of GFP in each 591 
cell clones were shown. The average value of population was shown by 592 
horizontal line. (E) Frequency distribution table. IN-dependent (n=17) and 593 
IN-independent (n=30) were distributed by MFI. 594 
 595 
Fig. 3. The involvement of IN-independent integration in replication 596 
competent HIV-1 replication. 597 
(A) The experimental procedure is shown. Irradiated (IR(+)) or untreated 598 
(IR(-)) Jurkat cells were infected with replication competent HIV-1 NL4-3 in 599 
the presence of an IN inhibitor. At 3 dpi, the IN inhibitor and free viral 600 
particles were removed with extensive wash. To expand viral replication, 601 
fresh Jurkat cells were added and the p24CA viral antigen in culture 602 
medium was monitored over the course of 15 days. (B) The p24CA viral 603 
antigen in culture medium. (C) The copy number of integrated and 2LTR 604 
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form of HIV DNA at day 0. All experiments were performed in triplicate 605 
(n=3) in B and C. The error bars in B and C show standard deviations. Heat 606 
inactivated virus treated at 60 ˚C for 2 hr was used as the negative control. 607 
IN inhibitors, Ral or Elv, is indicated in top (C and D). The control 608 
experiment was performed in the absence of IN inhibitor and indicated as 609 



































































































































































































































































































































































































































































































Table 1. Integration sites analysis
Pathway Total Events In RefSeq*3 (%)*4 In repeat Seq (%)*5 Deletion or Insertion (%)*6
IN-dependent*1 49 40 84.4 1 2.2 3 6.1
IN-independent*2 79 54 68.4 15 19.0 21 26.6
P=0.098 P=0.0048 P=0.0039
*1: This result summarizes 40 sites derived from LTIG vector infected and 9 sites derived from CS-CDF-EG-Pre infected cells.
*2: This result summarizes 9 sites derived from LTIG vector infected and 75 sites derived from CS-CDF-EG-Pre infected cells.
       Of these sites, 6 are the results from WT+Elv and 76 six are from D64V. Then, 13 out of 79 results were derived from pre-
       irradiated culture.
*3: Integration events counted as insertion into reference sequence (=gene coding resion). 
*4: A frequency of integration into RefSeq. Random integration into RefSeq is expected to be 33% of total integration sites.
*5: A frequency of integration into repeat sequence.
*6: A frequency of integration with deletion in LTR sequence or with up to 50 bp insertion in LTR-host genome junction.
